Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. South Korea was up 33.5% of Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing in 2015, compared to a year earlier.
  2. Since 2014 Belgium Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing increased 6.1% year on year close to €241.2 Per Capita.
  3. In 2019 Finland was ranked number 6 in Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing.
  4. In 2017 Switzerland was number 1 in Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing close to €829 Per Capita, from 13 in 2016.

Top Countries in Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing

Euros Per Capita - 2005 to 2019

# 14 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
829.00 2017 NA +2.1 % View data
2 #2
Belgium
241.20 2019 +3.0 % +6.1 % View data
3 #3
Sweden
118.70 2017 NA NA View data
4 #4
United Kingdom
82.10 2019 -0.6 % +1.7 % View data
5 #5
France
44.80 2017 -1.5 % -1.4 % View data
6 #6
Finland
35.40 2019 +0.8 % +2.8 % View data
7 #7
South Korea
21.10 2015 +33.5 % +13.6 % View data
8 #8
Portugal
12.40 2019 -1.6 % +7.8 % View data
9 #9
Italy
11.00 2019 -1.8 % -1.4 % View data
10 #10
Czech Republic
7.50 2019 -3.9 % +6.8 % View data
11 #11
Poland
3.10 2019 +3.3 % +12.8 % View data
12 #12
Malta
2.70 2019 -22.9 % -18.3 % View data
13 #13
Slovakia
0.50 2019 -16.7 % +0.0 % View data
14 #14
Romania
0.40 2017 -20.0 % NA View data

Source: European Commission

Go Top